Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $1.00 per share
-
Shares outstanding
-
7.36M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
2.31M
-
Shares change
-
-66.5K
-
Total reported value, excl. options
-
$29.2M
-
Value change
-
-$748K
-
Number of buys
-
10
-
Number of sells
-
-4
-
Price
-
$12.74
Significant Holders of HARTE HANKS INC - Common Stock, par value $1.00 per share (HHS) as of Q2 2022
17 filings reported holding HHS - HARTE HANKS INC - Common Stock, par value $1.00 per share as of Q2 2022.
HARTE HANKS INC - Common Stock, par value $1.00 per share (HHS) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.31M shares
of 7.36M outstanding shares and own 31.33% of the company stock.
Largest 10 shareholders include WESTERLY CAPITAL MANAGEMENT, LLC (1.08M shares), BLAIR WILLIAM & CO/IL (661K shares), CREDIT SUISSE AG/ (129K shares), Eidelman Virant Capital (126K shares), VANGUARD GROUP INC (105K shares), EAM Investors, LLC (73.9K shares), RENAISSANCE TECHNOLOGIES LLC (51.6K shares), GEODE CAPITAL MANAGEMENT, LLC (33.1K shares), ACADIAN ASSET MANAGEMENT LLC (14.4K shares), and Virtu Financial LLC (11.7K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.